Pharmasol

Hydroxa (Hydroxyurea) 500mg Tablets – 10s Pack is a powerful medicine used for treating chronic myeloid leukemia (CML), head and neck cancer, and sickle cell anemia. Hydroxyurea works by interfering with the growth of cancer cells, helping the body destroy them effectively. It also helps prevent painful episodes and reduces the need for blood transfusions in patients with sickle cell anemia by making red blood cells more flexible. Each Hydroxa (Hydroxyurea) 500mg Tablet is carefully formulated to deliver the right dose based on your body weight. Your doctor will determine the proper dosage, which may vary depending on whether it is being used for CML, head and neck cancer, or sickle cell anemia. Hydroxyurea is available in a convenient oral capsule form for easy administration. Hydroxa (Hydroxyurea) 500mg Tablets comes with essential precautions. It may temporarily lower white blood cells and platelets, increasing the risk of infection and bleeding. Patients should follow hygiene precautions, avoid contact sports, and consult a doctor immediately if any unusual symptoms occur. Pregnant women and those planning pregnancy should avoid use, as Hydroxyurea can harm an unborn baby. Get your Hydroxa (Hydroxyurea) 500mg Tablets – 10s Pack today and manage your CML, head and neck cancer, or sickle cell anemia effectively. Trusted, reliable, and doctor-recommended, Hydroxyurea ensures optimal care for patients.

Read more less

Eltrom (Eltrombopag) Tablets 25mg are highly effective oral medicines used for the treatment of low platelet count (thrombocytopenia) caused by conditions like chronic immune thrombocytopenia (ITP), aplastic anemia, and liver disease-related thrombocytopenia. These tablets contain Eltrombopag 25mg, a modern thrombopoietin receptor agonist that stimulates the bone marrow to produce healthy platelets, helping prevent bleeding, bruising, and other complications caused by low platelet levels. Doctors frequently prescribe Eltrom (Eltrombopag) Tablets 25mg for patients with chronic ITP, where the immune system destroys platelets, and for those with aplastic anemia who require additional platelet support. Eltrombopag 25mg works by enhancing platelet production naturally, offering an oral, convenient, and effective alternative to injectable therapies. Patients using Eltrom tablets should follow the prescribed dosage and undergo regular blood tests to monitor platelet levels. Eltrombopag Tablets 25mg are suitable for long-term use under medical supervision and are widely trusted as a safe and effective low platelet count treatment medicine. Eltrom (Eltrombopag) Tablets 25mg are available at licensed online pharmacies, offering reliable, genuine Eltrombopag tablets for patients seeking quality thrombocytopenia treatment. These tablets improve overall health, reduce bleeding risks, and support better platelet recovery in patients with blood disorders. Uses Eltrombopag is used to treat thrombocytopenia (low platelets in the blood) in patients with a blood disorder called chronic immune thrombocytopenia (ITP). This medicine is used after a splenectomy (surgery to remove the spleen) and other medicines (eg, steroids or immunoglobulin) have not worked well enough. Eltrombopag is also used to treat thrombocytopenia in patients with chronic hepatitis C, along with interferon treatment. Platelets help clot the blood, so a person with thrombocytopenia may have bleeding problems. Eltrombopag works by stimulating the bone marrow to produce more platelets. Eltrombopag is used together with standard immunosuppressive treatment for the first-line treatment of severe aplastic anemia (SAA) in adults and children 2 years of age and older. It is also used to treat SAA in patients who have received other medicines that did not work well. Dosage The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so. The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine. For first-line treatment of severe aplastic anemia:For oral dosage forms (Promacta® suspension or tablets):Adults and children 12 years of age and older—At first, 150 milligrams (mg) once a day for 6 months. Some patients may start at a lower dose. Your doctor may adjust your dose as needed.Children 6 to 11 years of age—At first, 75 mg once a day for 6 months. Some patients may start at a lower dose. Your doctor may adjust your dose as needed.Children 2 to 5 years of age—Dose is based on weight and must be determined by your doctor. At first, 2.5 milligram per kilogram (mg/kg) of body weight once a day for 6 months. Some patients may start at a lower dose. Your doctor may adjust your dose as needed.Children younger than 2 years of age—Use and dose must be determined by your doctor.For refractory severe aplastic anemia:For oral dosage forms (Promacta® suspension or tablets):Adults—At first, 50 milligrams (mg) once a day. Some patients may start at a lower dose. Your doctor may adjust your dose as needed. However, the dose is usually not more than 150 mg per day.Children—Use and dose must be determined by your doctor. Warnings and Precautions In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered: AllergiesTell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully. PediatricAlvaiz™: Appropriate studies have not been performed on the relationship of age to the effects of eltrombopag for the treatment of ITP in children younger than 6 years of age and for the treatment of chronic hepatitis C and severe aplastic anemia in children. Safety and efficacy have not been established. Promacta®: Safety and efficacy have not been established to treat ITP in children younger than 1 year of age, or in children with thrombocytopenia associated with chronic hepatitis C or severe aplastic anemia. GeriatricAppropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of eltrombopag in the elderly. However, elderly patients are more likely to have age-related liver problems, which may require caution and an adjustment in the dose for patients receiving eltrombopag. BreastfeedingThere are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.Eltrombopag may cause or increase the risk for serious liver problems. Check with your doctor right away if you or your child start having nausea or vomiting, dark urine, light-colored stools, right upper stomach pain, unusual tiredness, or yellow eyes or skin while using this medicine. This medicine may increased risk for blood or bone marrow problems (eg, myelodysplastic syndrome, acute myeloid leukemia). Check with your doctor right away if you have chest pain, chills, cough or hoarseness, fever, lower back or side pain, painful or difficult urination, sores, ulcers, or white spots on the lips or in the mouth, swollen glands, unusual bleeding or bruising, or unusual tiredness or weakness. Blood clotting problems may occur while you or your child are using this medicine. Check with your doctor right away if you or your child have pain, swelling, or tenderness in your leg, or pain in your chest. Do not stop using this medicine without checking first with your doctor. Your doctor will check your platelet levels and progress before you stop using the medicine. This medicine may cause cataracts or make them worse. Check with your doctor right away if you or your child have blurred vision, difficulty in reading, or any other change in vision while using this medicine. Your doctor may want your eyes be checked by an ophthalmologist (eye doctor). Make sure any doctor or dentist who treats you knows that you are using this medicine. This medicine may affect certain medical test results (eg, bilirubin, creatinine). Do not take other medicines unless they have been discussed with your doctor. This includes prescription or nonprescription (over-the-counter [OTC]) medicines and herbal or vitamin supplements.

Read more less

Eltrom (Eltrombopag) Tablets 50mg are used to treat low platelet count (thrombocytopenia) in patients with immune thrombocytopenic purpura (ITP) and chronic liver disease. Eltrom 50mg tablets work by stimulating platelet production in the bone marrow, helping reduce the risk of bleeding. Doctors prescribe Eltrombopag tablets 50mg to patients who do not respond adequately to standard treatments. Eltrom Tablets are widely used in hematology and require regular monitoring under medical supervision. If you are searching for Eltrom Eltrombopag 50mg tablets, platelet booster medicine, or Eltrombopag tablets price, this product provides reliable therapeutic support. Uses Eltrombopag is used to treat thrombocytopenia (low platelets in the blood) in patients with a blood disorder called chronic immune thrombocytopenia (ITP). This medicine is used after a splenectomy (surgery to remove the spleen) and other medicines (eg, steroids or immunoglobulin) have not worked well enough. Eltrombopag is also used to treat thrombocytopenia in patients with chronic hepatitis C, along with interferon treatment. Platelets help clot the blood, so a person with thrombocytopenia may have bleeding problems. Eltrombopag works by stimulating the bone marrow to produce more platelets. Eltrombopag is used together with standard immunosuppressive treatment for the first-line treatment of severe aplastic anemia (SAA) in adults and children 2 years of age and older. It is also used to treat SAA in patients who have received other medicines that did not work well. Dosage The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so. The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine. For first-line treatment of severe aplastic anemia:For oral dosage forms (Promacta® suspension or tablets):Adults and children 12 years of age and older—At first, 150 milligrams (mg) once a day for 6 months. Some patients may start at a lower dose. Your doctor may adjust your dose as needed.Children 6 to 11 years of age—At first, 75 mg once a day for 6 months. Some patients may start at a lower dose. Your doctor may adjust your dose as needed.Children 2 to 5 years of age—Dose is based on weight and must be determined by your doctor. At first, 2.5 milligram per kilogram (mg/kg) of body weight once a day for 6 months. Some patients may start at a lower dose. Your doctor may adjust your dose as needed.Children younger than 2 years of age—Use and dose must be determined by your doctor.For refractory severe aplastic anemia:For oral dosage forms (Promacta® suspension or tablets):Adults—At first, 50 milligrams (mg) once a day. Some patients may start at a lower dose. Your doctor may adjust your dose as needed. However, the dose is usually not more than 150 mg per day.Children—Use and dose must be determined by your doctor. Warnings and Precautions In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered: AllergiesTell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully. PediatricAlvaiz™: Appropriate studies have not been performed on the relationship of age to the effects of eltrombopag for the treatment of ITP in children younger than 6 years of age and for the treatment of chronic hepatitis C and severe aplastic anemia in children. Safety and efficacy have not been established. Promacta®: Safety and efficacy have not been established to treat ITP in children younger than 1 year of age, or in children with thrombocytopenia associated with chronic hepatitis C or severe aplastic anemia. GeriatricAppropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of eltrombopag in the elderly. However, elderly patients are more likely to have age-related liver problems, which may require caution and an adjustment in the dose for patients receiving eltrombopag. BreastfeedingThere are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.Eltrombopag may cause or increase the risk for serious liver problems. Check with your doctor right away if you or your child start having nausea or vomiting, dark urine, light-colored stools, right upper stomach pain, unusual tiredness, or yellow eyes or skin while using this medicine. This medicine may increased risk for blood or bone marrow problems (eg, myelodysplastic syndrome, acute myeloid leukemia). Check with your doctor right away if you have chest pain, chills, cough or hoarseness, fever, lower back or side pain, painful or difficult urination, sores, ulcers, or white spots on the lips or in the mouth, swollen glands, unusual bleeding or bruising, or unusual tiredness or weakness. Blood clotting problems may occur while you or your child are using this medicine. Check with your doctor right away if you or your child have pain, swelling, or tenderness in your leg, or pain in your chest. Do not stop using this medicine without checking first with your doctor. Your doctor will check your platelet levels and progress before you stop using the medicine. This medicine may cause cataracts or make them worse. Check with your doctor right away if you or your child have blurred vision, difficulty in reading, or any other change in vision while using this medicine. Your doctor may want your eyes be checked by an ophthalmologist (eye doctor). Make sure any doctor or dentist who treats you knows that you are using this medicine. This medicine may affect certain medical test results (eg, bilirubin, creatinine). Do not take other medicines unless they have been discussed with your doctor. This includes prescription or nonprescription (over-the-counter [OTC]) medicines and herbal or vitamin supplements.

Read more less

Crisvin (Vincristine) Injection 1mg/1ml is a powerful anticancer chemotherapy medicine used in the treatment of various types of cancers, including leukemia, lymphoma, Hodgkin’s disease, non-Hodgkin lymphoma, and certain solid tumors. Vincristine injection works by inhibiting the growth of cancer cells by interfering with cell division, which ultimately slows down or stops the spread of cancer in the body. Oncologists commonly include Crisvin injection in combination chemotherapy regimens to enhance treatment effectiveness. This chemotherapy injection is administered intravenously under strict medical supervision in hospital or clinical settings. Crisvin Vincristine injection plays a vital role in pediatric and adult oncology protocols. Patients searching for Vincristine injection 1mg, Crisvin chemotherapy injection, or buy Vincristine online in Pakistan can rely on this medicine for hospital-grade quality and proven therapeutic efficacy. Regular monitoring during treatment ensures patient safety and optimal cancer control. Uses Vincristine belongs to the group of medicines known as antineoplastic agents. It is used to treat some kinds of cancer as well as some noncancerous conditions. Vincristine interferes with the growth of cancer cells, which are eventually destroyed.  Dosage The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so. The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine. Warnings and Precautions In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered: AllergiesTell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully. PediatricThis medicine has been tested in children and has not been shown to cause different side effects or problems than it does in adults. GeriatricNervous system effects may be more likely to occur in the elderly, who are usually more sensitive to the effects of vincristine. BreastfeedingThere are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.It is very important that your doctor check your progress at regular visits to make sure that vincristine is working properly and to check for unwanted effects. While you are being treated with vincristine, and after you stop treatment with it, do not have any immunizations (vaccinations) without your doctor's approval. Vincristine may lower your body's resistance and there is a chance you might get the infection the immunization is meant to prevent. Other people living in your household should not take or should not have recently taken oral polio vaccine since there is a chance they could pass the polio virus on to you. Also, avoid other persons who have taken oral polio vaccine. Do not get close to them, and do not stay in the same room with them for very long. If you cannot take these precautions, you should consider wearing a protective face mask that covers the nose and mouth. If vincristine accidentally seeps out of the vein into which it is injected, it may damage some tissues and cause scarring. Tell the doctor or nurse right away if you notice redness, pain, or swelling at the place of injection.

Read more less

Trexat (Methotrexate) Tablets 10mg is used to treat cancer, rheumatoid arthritis, psoriasis, and autoimmune diseases. It works by slowing abnormal cell growth and suppressing immune system activity.Methotrexate is commonly prescribed by specialists for long-term disease management under medical supervision.Buy Trexat 10mg tablets online in Pakistan from a trusted pharmacy ensuring genuine medication. Uses Methotrexate tablet is used alone or together with other medicines to treat several types of cancer, such as breast, head and neck, lung, blood (eg, acute lymphoblastic leukemia or ALL), bone, lymph node (eg, mycosis fungoides, relapsed or refractory non-Hodgkin lymphoma), or uterus cancer. It is also used to treat rheumatoid arthritis, severe psoriasis (a skin disease), lupus, multiple sclerosis, and polyarticular juvenile idiopathic arthritis. Methotrexate oral solution is used together with other medicines to treat acute lymphoblastic leukemia (ALL) or non-Hodgkin lymphoma that has come back (relapsed) or did not respond to previous treatment (refractory). It is also used alone or together with other medicines to treat mycosis fungoides. This medicine is also used to treat rheumatoid arthritis, severe psoriasis (a skin disease), and polyarticular juvenile idiopathic arthritis. Dosage The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so. The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine. For oral dosage form (tablets):For acute lymphoblastic leukemia (ALL):Adults and children—Dose is based on body size and must be determined by your doctor. At first, 20 milligrams (mg) per meter squared (m(2)) of body size once a week. Your doctor may adjust your dose as needed and tolerated.For mycosis fungoides:Adults—Used alone: 25 to 75 milligrams (mg) once a week.Used with other medicines: Dose is based on body size and must be determined by your doctor. The dose is usually 10 mg per meter squared (m(2)) of body size 2 times a week.Children—Use and dose must be determined by your doctor.For non-Hodgkin lymphoma:Adults—2.5 milligrams (mg) 2 to 4 times a week. Your doctor may adjust your dose as needed and tolerated. However, the dose is usually not more than 10 mg per week.Children—Use and dose must be determined by your doctor.For polyarticular juvenile arthritis (pJIA):Children—Dose is based on body size and must be determined by your doctor. At first, 10 milligrams (mg) per meter squared (m2) once a week. Your doctor may adjust your dose as needed and tolerated.For psoriasis:Adults—At first, 10 to 25 milligrams (mg) once a week. Your doctor may adjust your dose as needed and tolerated. However, the dose is usually not more than 30 mg per week.Children—Use and dose must be determined by your doctor.For rheumatoid arthritis:Adults—At first, 7.5 milligrams (mg) once a week. Your doctor may adjust your dose as needed and tolerated.Children—Use and dose must be determined by your doctor. Warnings and Precautions In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered: AllergiesTell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully. PediatricAppropriate studies performed to date have not demonstrated pediatric-specific problems that would limit the usefulness of methotrexate for the treatment of acute lymphoblastic leukemia and polyarticular juvenile idiopathic arthritis in children. However, safety and efficacy have not been established in children with other conditions. GeriatricAppropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of methotrexate in the elderly. BreastfeedingStudies in women breastfeeding have demonstrated harmful infant effects. An alternative to this medication should be prescribed or you should stop breastfeeding while using this medicine.It is very important that your doctor check your progress at regular visits to make sure this medicine is working properly and to check for unwanted effects. Blood and urine tests may be needed to check for unwanted effects. Using this medicine while you are pregnant can harm your unborn baby. The medicine may also cause birth defects if it is used by the father when his sexual partner becomes pregnant. If you are a woman who can bear children, your doctor may give you a pregnancy test before you start using this medicine to make sure you are not pregnant. Female patients should use an effective form of birth control during treatment and for at least 3 or 6 months after the last dose. Male patients who have female partners should use an effective form of birth control during treatment and for at least 3 months after the last dose. Tell your doctor right away if pregnancy occurs while you are using this medicine. This medicine may cause serious allergic reactions, including anaphylaxis, which may be life-threatening and require immediate medical attention. Check with your doctor right away if you have a rash, itching, dizziness, fainting, fast heartbeat, trouble breathing or swallowing, or chest tightness while you are using this medicine. Talk with your doctor before using this medicine if you plan to have children. Some men and women who use this medicine have become infertile (unable to have children).

Read more less

Glynib (Imatinib) Capsules 100mg are highly effective targeted cancer medicines used worldwide for the treatment of chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST). Glynib (Imatinib) Capsules 100mg belong to the class of tyrosine kinase inhibitors, a modern category of cancer treatment medicines designed to block abnormal proteins that trigger uncontrolled cancer cell growth. Imatinib 100mg capsules work by specifically targeting cancer-causing enzymes, helping stop the spread of cancer cells while protecting healthy tissue. This targeted action makes Imatinib Capsules 100mg one of the most trusted options for long-term CML treatment and GIST treatment under specialist medical supervision. Oncologists frequently recommend Glynib (Imatinib) Capsules 100mg for patients with Philadelphia chromosome-positive chronic myeloid leukemia, including early, accelerated, and advanced phases of the disease. In addition to leukemia care, Glynib (Imatinib) Capsules 100mg are also prescribed for gastrointestinal stromal tumors (GIST), where Imatinib 100mg helps reduce tumor growth, control disease progression, and lower the risk of recurrence after surgery. Continuous therapy with Imatinib Capsules has been shown to improve survival rates and enhance overall quality of life for cancer patients. As a trusted oral cancer medicine, Glynib (Imatinib) Capsules 100mg offer the convenience of capsule dosing, making long-term cancer treatment more manageable. Patients using Imatinib 100mg capsules should follow their oncologist’s instructions carefully and undergo regular monitoring to ensure safety and maximum therapeutic benefit. Available through licensed online pharmacies, Glynib (Imatinib) Capsules 100mg provide a reliable, effective, and targeted solution for patients seeking genuine Imatinib cancer treatment for CML and GIST.   Uses Imatinib is used alone or together with other medicines to treat different types of cancer or bone marrow conditions. It prevents or stops the growth of cancer cells and is called an antineoplastic (cancer) agent. Imatinib is used for these conditions: Aggressive systemic mastocytosis (ASM)Chronic eosinophilic leukemia (CEL)Dermatofibrosarcoma protuberans (DFSP)Gastrointestinal stromal tumors (GIST)Hypereosinophilic syndrome (HES)Myelodysplastic syndrome (MDS)Myeloproliferative diseases (MPD)Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL)Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) Dosage The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine. For oral dosage form (tablets):For the treatment of aggressive systemic mastocytosis (ASM):Adults—400 milligrams (mg) once a day. Your doctor may adjust your dose as needed.Children—Use and dose must be determined by your doctor.For the treatment of chronic eosinophilic leukemia (CEL) or hypereosinophilic syndrome (HES):Adults—400 milligrams (mg) once a day. Your doctor may adjust your dose as needed.Children—Use and dose must be determined by your doctor.For the treatment of dermatofibrosarcoma protuberans (DFSP):Adults—800 milligrams (mg) per day as a single dose or divided and given as 400 mg 2 times per day.Children—Use and dose must be determined by your doctor.For the treatment of gastrointestinal stromal tumors (GIST):Adults—400 milligrams (mg) once a day. Your doctor may adjust your dose as needed. However, the dose is usually not more than 800 mg per day.Children—Use and dose must be determined by your doctor.For the treatment of myelodysplastic syndrome (MDS) or myeloproliferative diseases (MPD):Adults—400 milligrams (mg) once a day.Children—Use and dose must be determined by your doctor.For the treatment of Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL):Adults—600 milligrams (mg) once a day.Children 1 year of age and older—Dose is based on body size and must be determined by your doctor. The dose is usually 340 milligrams per square meter (mg/m[2]) per day. The dose may be taken once a day or the dose may be divided into two small doses (once in the morning and once in the evening). However, the dose is usually not more than 600 mg per day.Children younger than 1 year of age—Use and dose must be determined by your doctor.For the treatment of accelerated phase or blast crisis Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML):Adults—600 milligrams (mg) once a day.Children 1 year of age and older—Dose is based on body size and must be determined by your doctor. The dose is usually 340 milligrams per square meter (mg/m[2]) per day. The dose may be taken once a day or the dose may be divided into two small doses (once in the morning and once in the evening). However, the dose is usually not more than 600 mg per day.Children younger than 1 year of age—Use and dose must be determined by your doctor.For the treatment of chronic phase Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML):Adults—400 milligrams (mg) once a day. Your doctor may adjust your dose as needed. However, the dose is usually not more than 800 mg per day.Children 1 year of age and older—Dose is based on body size and must be determined by your doctor. The dose is usually 340 milligrams per square meter (mg/m[2]) per day. The dose may be taken once a day or divided into 2 small doses (once in the morning and once in the evening). However, the dose is usually not more than 600 mg per day.Children younger than 1 year of age—Use and dose must be determined by your doctor. Warnings and Precautions In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered: AllergiesTell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully. PediatricAppropriate studies have not been performed on the relationship of age to the effects of imatinib to treat Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in chronic phase and acute lymphoblastic leukemia (Ph+ ALL) in children younger than 1 year of age and to treat other conditions in children. Safety and efficacy have not been established. GeriatricAppropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of imatinib in the elderly. However, serious side effects (eg, swelling of the face, hands, fingers, feet, or lower legs, and unusual weight gain) may be more likely to occur in elderly patients, who may be more sensitive than younger adults to the effects of imatinib. BreastfeedingThere are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.Using this medicine while you are pregnant can harm your unborn baby. If you can get pregnant, your doctor may do tests to make sure you are not pregnant before starting treatment. Use a highly effective form of birth control to keep from getting pregnant during treatment and for 14 days after your last dose of this medicine. If you think you have become pregnant while using the medicine, tell your doctor right away. Serious skin reactions, including erythema multiforme and Stevens-Johnson syndrome can occur during treatment with this medicine. Check with your doctor right away if you have blistering, peeling, or loosening of the skin, red skin lesions, severe acne or skin rash, sores or ulcers on the skin, or fever or chills while you are using this medicine. Some serious side effects including black, tarry stools, severe stomach pain, or vomiting of blood or material that looks like coffee grounds can occur during treatment with this medicine. While you are being treated with imatinib, and after you stop treatment with it, do not have any immunizations (vaccinations) without your doctor's approval. Imatinib may lower your body's resistance and there is a chance you might get the infection the immunization is meant to prevent. In addition, other persons living in your household should not take oral polio vaccine since there is a chance they could pass the polio virus on to you. Also, avoid persons who have recently taken oral polio vaccine. Do not get close to them and do not stay in the same room with them for very long. If you cannot take these precautions, you should consider wearing a protective face mask that covers the nose and mouth. Imatinib can temporarily lower the number of white blood cells in your blood, increasing the chance of getting an infection. It can also lower the number of platelets, which are necessary for proper blood clotting. If this occurs, there are certain precautions you can take, especially when your blood count is low, to reduce the risk of infection or bleeding:If you can, avoid people with infections. Check with your doctor immediately if you think you are getting an infection or if you get a fever or chills, cough or hoarseness, lower back or side pain, or painful or difficult urination.Check with your doctor immediately if you notice any unusual bleeding or bruising, black, tarry stools, blood in the urine or stools, or pinpoint red spots on your skin.Be careful when using a regular toothbrush, dental floss, or toothpick. Your medical doctor, dentist, or nurse may recommend other ways to clean your teeth and gums. Check with your medical doctor before having any dental work done.Do not touch your eyes or the inside of your nose unless you have just washed your hands and have not touched anything else in the meantime.Be careful not to cut yourself when you are using sharp objects such as a safety razor or fingernail or toenail cutters.Avoid contact sports or other situations where bruising or injury could occur.This medicine may cause slowed growth and development in children. Your child's doctor may want to monitor their weight and growth regularly. Talk to your child's doctor if you have concerns. This medicine may cause a serious type of reaction called tumor lysis syndrome. Your doctor may give you a medicine to help prevent this. Call your doctor right away if you have a decrease or change in urine amount, joint pain, stiffness, or swelling, lower back, side, or stomach pain, a rapid weight gain, swelling of the feet or lower legs, or unusual tiredness or weakness.

Read more less